3lshak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis[ J]. J Hepatol, 1995,22:696-699.
4Perrone G, Santini D, Vincenzi B, et al. COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features [ J ]. Histopathology,2005,46:561 -568.
5Cheng J, lmanishi H, lijima H, et al. Expression of cyclooxygenase 2 and cytosolic phosphlipase A (2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis [ J ]. Hepatol Res,2002,23 : 185 - 195.
6Tabemero A, Schneider F, Potenza M A, et al. COX-2 and inducible nitric oxide synthase in omental arteries harvested from pateints with severe liver disease: immuno-localization and influence on vascular tone[ J]. Intensive Care Med, 2003,29:262 -270.
7Oliveira V M, Piato S, Silva M A L G. Correlation of COX-2 and aromatase immunohistochemical expression in invasive ductal carcinoma,ductal carcinoma in situ, and adjacent normal epithelium[ J]. Breast Cancer Res Treat, 2006,95:235 -241.
8Cheng A S L, Chan H L Y, Leung W K, et al. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2 [ J ]. Mod Pathol, 2004,17 : 1169 - 1179.
9Mohammed N A, EL-Aleem S A, EL-Hafiz H A, et al. Distribution of constitutive ( COX-1 ) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis[ J]. J Clin Pathol, 2004,54 :350 - 354.
10Giambartolomei S, Artini M, Almerighi C, et al. Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT1 phosphorylation[ J]. Hepatology, 1999,30:510 -516.
